Paper · 40211707
Brevilin A inhibits IL‑17A‑induced inflammation in psoriasis by modulating HSP 70.
Li CL and 8 others. Mol Med Rep, 2025. Cited by 2 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Brevilin A inhibits IL‑17A‑induced inflammation in psoriasis by modulating HSP 70. Papers, record 40211707. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40211707
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Psoriasis | Major topic |
| Interleukin-17 | Major topic |
| HSP70 Heat-Shock Proteins | Major topic |
| Inflammation | Major topic |
| Animals | |
| Humans | |
| Mice | |
| Cytokines | |
| HaCaT Cells | |
| Disease Models, Animal | |
| Keratinocytes | |
| Skin | |
| Cell Line | |
| Male |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16,834,562 | Stress protein expression kinetics. | Annu Rev Biomed Eng | 2006 | https://conductscience.org/library/papers/16834562 | PubMed |
| 2 | 27,696,208 | Structure-Based Drug Designing and Simulation Studies for Finding Novel Inhibitors of Heat Shock Protein (HSP70) as Suppressors for Psoriasis. | Interdiscip Sci | 2018 | https://conductscience.org/library/papers/27696208 | PubMed |
| 3 | 36,041,498 | Activation of TREM2 attenuates neuroinflammation via PI3K/Akt signaling pathway to improve postoperative cognitive dysfunction in mice. | Neuropharmacology | 2022 | https://conductscience.org/library/papers/36041498 | PubMed |
| 4 | 11,533,664 | Heat-shock protein 70 antagonizes apoptosis-inducing factor. | Nat Cell Biol | 2001 | https://conductscience.org/library/papers/11533664 | PubMed |
| 5 | 21,283,720 | The Hsc/Hsp70 co-chaperone network controls antigen aggregation and presentation during maturation of professional antigen presenting cells. | PLoS One | 2011 | https://conductscience.org/library/papers/21283720 | PubMed |
| 6 | 37,686,332 | Inhibition of NLRP3 Inflammasome Activation by 3H-1,2-Dithiole-3-Thione: A Potential Therapeutic Approach for Psoriasis Treatment. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37686332 | PubMed |
| 7 | 29,226,422 | Pathogenesis of psoriasis and development of treatment. | J Dermatol | 2018 | https://conductscience.org/library/papers/29226422 | PubMed |
| 8 | 36,009,046 | Heat Shock Protein 90 (Hsp90) and Hsp70 as Potential Therapeutic Targets in Autoimmune Skin Diseases. | Biomolecules | 2022 | https://conductscience.org/library/papers/36009046 | PubMed |
| 9 | 31,316,496 | TRAF Regulation of IL-17 Cytokine Signaling. | Front Immunol | 2019 | https://conductscience.org/library/papers/31316496 | PubMed |
| 10 | 28,865,459 | Clinical efficacy and IL-17 targeting mechanism of Indigo naturalis as a topical agent in moderate psoriasis. | BMC Complement Altern Med | 2017 | https://conductscience.org/library/papers/28865459 | PubMed |
1 to 10 of 33
See all 33 referencesCited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,154,435 | Heat Shock Proteins as Cancer Biomarkers: From Mechanism to Clinical Application. | Mol Diagn Ther | 2026 | https://conductscience.org/library/papers/42154435 | PubMed |
| 42,055,684 | Keratinocyte-specific STAT3 knockout attenuates imiquimod-induced psoriasiform phenotype in mice. | Exp Anim | 2026 | https://conductscience.org/library/papers/42055684 | PubMed |
| 41,466,423 | Brevilin A reverses colitis of inflammatory bowel disease via modulation of TNF-α signaling and microbiome dysregulation. | Gut Pathog | 2025 | https://conductscience.org/library/papers/41466423 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CXCL8 | 3,576 | PubTator's text mining | https://conductscience.org/library/genes/3576 | NCBI Gene |
| HSP90AA1 | 3,320 | PubTator's text mining | https://conductscience.org/library/genes/3320 | NCBI Gene |
| HSPA4 | 3,308 | PubTator's text mining | https://conductscience.org/library/genes/3308 | NCBI Gene |
| IL17A | 3,605 | PubTator's text mining | https://conductscience.org/library/genes/3605 | NCBI Gene |
| IL6 | 3,569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40211707
GET https://conductscience.org/api/papers/v1/40211707/references?page=2